Testing for PDGFRB returns positive. What is the most appropriate treatment for this patient?
belongs to book: Hematology Case Review|Donald C. Doll & Radwan F. Khozouz & Wes Matthew Triplett|| Chapter number:78| Question number:3
All Answers
total answers (1)
D. Patients with CMML harboring PDGFRB translocations exhibit durable responses with the use of imatinib, which is considered the most appropriate therapy in the nonemergent setting in cases harboring PDGFRB translocations (NEfM. 2002;347(7):48 1, Blood. 2002;100(3):1088, Blood. 2007;109(1 ):61).
need an explanation for this answer? contact us directly to get an explanation for this answer